Marshall H Woodworth
CIK 1492648 · Chief Financial Officer · last filed 2026-01-27
Marshall H Woodworth is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for NRBO, was dated Jan 27, 2026. Across all open-market trades the lifetime net is +$101.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
11
$101.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. (NRBO) Delisted | Chief Financial Officer | 30,734 | $2.36 | $72.5K | $9.9K | 5 | 2026-01-27 |
| Furiex Pharmaceuticals, Inc. (FURX) Delisted | Chief Financial Officer | 16,411 | — | — | $91.8K | 6 | 2013-06-12 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-27 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +28,000 | $0 | EDGAR |
| 2025-08-13 | MetaVia Inc. (NRBO) Delisted | Gift (G) | −14,200 | $0 | EDGAR |
| 2025-06-04 | MetaVia Inc. (NRBO) Delisted | Buy (P) | +14,200 | $9.9K | EDGAR |
| 2025-03-04 | MetaVia Inc. (NRBO) Delisted | Tax (F) | −3,417 | -$5.0K | EDGAR |
| 2024-03-04 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +33,496 | $0 | EDGAR |
| 2013-06-12 | Furiex Pharmaceuticals, Inc. (FURX) Delisted | Grant (A) | +10,200 | $0 | EDGAR |
| 2012-04-11 | Furiex Pharmaceuticals, Inc. (FURX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-08 | Furiex Pharmaceuticals, Inc. (FURX) Delisted | Buy (P) | +6,211 | $91.8K | EDGAR |
| 2011-10-05 | Furiex Pharmaceuticals, Inc. (FURX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-11 | Furiex Pharmaceuticals, Inc. (FURX) Delisted | Grant (A) | — | $0 | EDGAR |